Viral Vector Manufacturing Industry Statistics

In this post, we explore key statistics and trends shaping the viral vector manufacturing industry, a rapidly growing sector with significant global impact. From market values and growth projections to regional market leaders and emerging technologies, these statistics shed light on the evolving landscape of viral vector production for gene therapy and beyond.

Statistic 1

"** As of 2020, the global value of the viral vector manufacturing market was estimated to be $289.9 million. **"

Statistic 2

"** The viral vector manufacturing market is projected to reach $815.8 million USD by 2023. **"

Statistic 3

"** The Compound Annual Growth Rate (CAGR) of the viral vector manufacturing industry is expected to be around 20.0% during 2018 to 2023. **"

Statistic 4

"** North America, particularly the United States, is the largest market for viral vector manufacturing. **"

Statistic 5

"** The discovery of new viral vectors for gene therapy applications has significantly boosted the growth of viral vector manufacturing. **"

Statistic 6

"** Europe is the second largest market for viral vector manufacturing, driven by rising gene therapy R&D and the presence of key players. **"

Statistic 7

"** GenCure, a subsidiary of BioBridge Global, expanded its viral vector manufacturing capacity in 2019 to meet the increasing demand for viral vectors. **"

Statistic 8

"** Asia Pacific is expected to witness the highest growth rate in the viral vector manufacturing market during the forecast period. **"

Statistic 9

"** The cancer disease segment is expected to account for the largest share of the viral vector manufacturing market. **"

Statistic 10

"** Lentivirus vectors account for the largest share in viral vector systems for gene therapy. **"

Statistic 11

"** Biopharmaceutical and biotechnology companies are the largest end-users of the viral vector manufacturing market. **"

Statistic 12

"** The viral vectors and RNAi therapeutics market in Latin America is projected to have a CAGR of 18.7% between 2020 and 2027. **"

Statistic 13

"** Thermo Fisher Scientific invested $1.5 billion in 2021 to expand its pharma service capabilities, which includes viral vector manufacturing. **"

Statistic 14

"** The growing prevalence of genetic disorders and targeted diseases is one of the primary growth drivers of the viral vector manufacturing industry. **"

Statistic 15

"** Retrovirus vector systems are the third most used viral vectors for gene therapy. **"

Statistic 16

"** More than 40% of gene therapies currently in development use adeno-associated virus vectors, making it the most popular viral vector. **"

Statistic 17

"** Insect cell culture was the most widely used method for viral vector production in 2021. **"

Statistic 18

"** The use of viral vectors in vaccine development has significantly increased due to the COVID-19 pandemic. **"

Statistic 19

"** Clinical applications account for over half of the demand for viral vectors, followed by commercial therapy manufacturing. **"

In conclusion, the viral vector manufacturing industry is experiencing significant growth and is poised for further expansion in the coming years. With a projected market value to reach $815.8 million USD by 2023, driven by a Compound Annual Growth Rate (CAGR) of 20.0% from 2018 to 2023, various regions such as North America, Europe, and Asia Pacific are playing key roles in shaping the market landscape. The increasing demand for viral vectors in gene therapy applications, particularly for treating cancer and genetic disorders, is fueling this growth, along with advancements in technology and investments by major players like Thermo Fisher Scientific. The diverse applications of viral vectors, from vaccine development to commercial therapy manufacturing, underscore their importance in the biopharmaceutical and biotechnology sectors. As new discoveries and innovations continue to drive this market forward, it is evident that the viral vector manufacturing industry is on a trajectory of substantial progress and impact.